Literature DB >> 17249647

Synthesis and pharmacophore modeling of naphthoquinone derivatives with cytotoxic activity in human promyelocytic leukemia HL-60 cell line.

Elisa Pérez-Sacau1, Raquel G Díaz-Peñate, Ana Estévez-Braun, Angel G Ravelo, Jose M García-Castellano, Leonardo Pardo, Mercedes Campillo.   

Abstract

Catalyst/HypoGen pharmacophore modeling approach and three-dimensional quantitative structure-activity relationship (3D-QSAR)/comparative molecular similarity indices analysis (CoMSIA) methods have been successfully applied to explain the cytotoxic activity of a set of 51 natural and synthesized naphthoquinone derivatives tested in human promyelocytic leukemia HL-60 cell line. The computational models have facilitated the identification of structural elements of the ligands that are key for antitumoral properties. The four most salient features of the highly active beta-cycled-pyran-1,2-naphthoquinones [0.1 microM < IC50 < 0.6 microM] are the hydrogen-bond interactions of the carbonyl groups at C-1 (HBA1) and C-2 (HBA2), the hydrogen-bond interaction of the oxygen atom of the pyran ring (HBA3), and the interaction of methyl groups (HYD) at the pyran ring with a hydrophobic area at the receptor. The moderately active 1,4-naphthoquinone derivatives accurately fulfill only three of these features. The results of our study provide a valuable tool in designing new and more potent cytotoxic analogues.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17249647     DOI: 10.1021/jm060849b

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  15 in total

1.  Structural simplification of bioactive natural products with multicomponent synthesis. 4. 4H-pyrano-[2,3-b]naphthoquinones with anticancer activity.

Authors:  Igor V Magedov; Artem S Kireev; Aaron R Jenkins; Nikolai M Evdokimov; Dustin T Lima; Paul Tongwa; Jeff Altig; Wim F A Steelant; Severine Van slambrouck; Mikhail Yu Antipin; Alexander Kornienko
Journal:  Bioorg Med Chem Lett       Date:  2012-07-04       Impact factor: 2.823

2.  Synthesis of quinone imine and sulphur-containing compounds with antitumor and trypanocidal activities: redox and biological implications.

Authors:  Renata G Almeida; Wagner O Valença; Luísa G Rosa; Carlos A de Simone; Solange L de Castro; Juliana M C Barbosa; Daniel P Pinheiro; Carlos R K Paier; Guilherme G C de Carvalho; Claudia Pessoa; Marilia O F Goulart; Ammar Kharma; Eufrânio N da Silva Júnior
Journal:  RSC Med Chem       Date:  2020-07-13

3.  It takes two to tango: synthesis of cytotoxic quinones containing two redox active centers with potential antitumor activity.

Authors:  Daisy J B Lima; Renata G Almeida; Guilherme A M Jardim; Breno P A Barbosa; Augusto C C Santos; Wagner O Valença; Marcos R Scheide; Claudia C Gatto; Guilherme G C de Carvalho; Pedro M S Costa; Claudia Pessoa; Cynthia L M Pereira; Claus Jacob; Antonio L Braga; Eufrânio N da Silva Júnior
Journal:  RSC Med Chem       Date:  2021-08-12

4.  Analysis of quinolinequinone reactivity, cytotoxicity, and anti-HIV-1 properties.

Authors:  Ayna Alfadhli; Andrew Mack; Logan Harper; Sam Berk; Christopher Ritchie; Eric Barklis
Journal:  Bioorg Med Chem       Date:  2016-09-12       Impact factor: 3.641

5.  Encapsulation of nor-β-lapachone into poly(d,l)-lactide-co-glycolide (PLGA) microcapsules: full characterization, computational details and cytotoxic activity against human cancer cell lines.

Authors:  Marcília P Costa; Anderson C S Feitosa; Fátima C E Oliveira; Bruno C Cavalcanti; Gleiston G Dias; Ewerton W S Caetano; Francisco A M Sales; Valder N Freire; Stefano Di Fiore; Rainer Fischer; Luiz O Ladeira; Eufrânio N da Silva Júnior; Claudia Pessoa
Journal:  Medchemcomm       Date:  2017-09-07       Impact factor: 3.597

6.  2-Bromo-1,4-naphthoquinone: a potentially improved substitute of menadione in Apatone™ therapy.

Authors:  F S Graciani; V F Ximenes
Journal:  Braz J Med Biol Res       Date:  2012-05-17       Impact factor: 2.590

7.  Pharmacophore modeling and in silico toxicity assessment of potential anticancer agents from African medicinal plants.

Authors:  Fidele Ntie-Kang; Conrad Veranso Simoben; Berin Karaman; Valery Fuh Ngwa; Philip Neville Judson; Wolfgang Sippl; Luc Meva'a Mbaze
Journal:  Drug Des Devel Ther       Date:  2016-07-04       Impact factor: 4.162

8.  Discovery of novel 1,2,3-triazole derivatives as anticancer agents using QSAR and in silico structural modification.

Authors:  Veda Prachayasittikul; Ratchanok Pingaew; Nuttapat Anuwongcharoen; Apilak Worachartcheewan; Chanin Nantasenamat; Supaluk Prachayasittikul; Somsak Ruchirawat; Virapong Prachayasittikul
Journal:  Springerplus       Date:  2015-10-05

Review 9.  Chiral Alkyl Halides: Underexplored Motifs in Medicine.

Authors:  Bálint Gál; Cyril Bucher; Noah Z Burns
Journal:  Mar Drugs       Date:  2016-11-04       Impact factor: 5.118

10.  Synthesis and antitumor activity of selenium-containing quinone-based triazoles possessing two redox centres, and their mechanistic insights.

Authors:  Eduardo H G da Cruz; Molly A Silvers; Guilherme A M Jardim; Jarbas M Resende; Bruno C Cavalcanti; Igor S Bomfim; Claudia Pessoa; Carlos A de Simone; Giancarlo V Botteselle; Antonio L Braga; Divya K Nair; Irishi N N Namboothiri; David A Boothman; Eufrânio N da Silva Júnior
Journal:  Eur J Med Chem       Date:  2016-06-14       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.